[
  {
    "ts": "2025-10-31T02:09:04+00:00",
    "headline": "Is Elevance Health (ELV) Undervalued After Recent 17% Share Price Rally?",
    "summary": "Elevance Health (ELV) has seen some movement in its share price lately, prompting investors to take a closer look at recent performance trends. Over the past 3 months, the stock is up around 17%. See our latest analysis for Elevance Health. Elevance Health has experienced some volatility, but the share price rally of 17% over the past quarter stands out given the backdrop of a 12% year-to-date decline and a 1-year total shareholder return loss of 19%. Recent moves suggest momentum could be...",
    "url": "https://finance.yahoo.com/news/elevance-health-elv-undervalued-recent-020904197.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "20e77bae-d365-312a-8e77-0e8f8741584c",
      "content": {
        "id": "20e77bae-d365-312a-8e77-0e8f8741584c",
        "contentType": "STORY",
        "title": "Is Elevance Health (ELV) Undervalued After Recent 17% Share Price Rally?",
        "description": "",
        "summary": "Elevance Health (ELV) has seen some movement in its share price lately, prompting investors to take a closer look at recent performance trends. Over the past 3 months, the stock is up around 17%. See our latest analysis for Elevance Health. Elevance Health has experienced some volatility, but the share price rally of 17% over the past quarter stands out given the backdrop of a 12% year-to-date decline and a 1-year total shareholder return loss of 19%. Recent moves suggest momentum could be...",
        "pubDate": "2025-10-31T02:09:04Z",
        "displayTime": "2025-10-31T02:09:04Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/3e695c35ab2bf9c83822def1d840a300",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/En2KzBqo8SXnCw89zK0WLw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/3e695c35ab2bf9c83822def1d840a300.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BoUVqO_whCETSPZRsj9Bbg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/3e695c35ab2bf9c83822def1d840a300.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/elevance-health-elv-undervalued-recent-020904197.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/elevance-health-elv-undervalued-recent-020904197.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ELV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]